CathWorks

Headquarters: Kfar Sava, Israel

Investor Relations:

Description

CathWorks is a medical technology company focused on applying its advanced computational science platform to optimize Coronary Artery Disease (CAD) therapy decisions and elevate coronary angiography from visual assessment to an objective FFR-based decision-making tool for physicians. FFR-guided PCI decision-making is proven to provide significant clinical benefits for patients with coronary artery disease and economic benefits for patients and payers. The company’s focus today is specifically on bringing the CathWorks FFRangio™ System to market to provide quick, precise, and objective intraprocedural wire-free FFR guidance that is practical for every case.

Industry

Medical Devices

Year Founded

Website

https://www.cath.works/

Ownership

Private

Chief Executive Officer

Chairman of the Board

Chief Financial Officer

Insider Ownership

Key Investors

Employee Count

Trailing Revenues

Trailing Operating Profits

Trailing Net Income

Most Recent Raise (Date)

Round

Capital Raised

Auditors

Investment Bankers

Law Firm

In the CEOs Own Words

Corporate Mission

Proudest Accomplishment

Next Milestone

Geographic Markets Served

Growth Drivers

Growth Headwinds

Indicia of Customer Satisfaction

Scalability

Workforce

Focus of Recruitment

Research and Development

Patent Count

Economic Sensitivity

Unique Metrics

Greatest Concern

Company Reports and Communications

Company Press Releases

Reports

Podcasts

Open Questions to Management

Chatboard